Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
This piece reviews index funds that pair well with Roth IRA rollovers, emphasizing broad market exposure and cost efficiency for easier long-term growth.
24,079 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Analysts are weighing a path for synopsys stock $600 march targets as AI-driven chip design demand grows, even as deb...
ADA slumped about 40% in June, trading near $0.16 as Bitcoin stayed near $60,000. Analysts say zero price is unlikely...
A coalition of over 200 crypto firms is pressing Congress for a floor vote on the CLARITY Act, warning that time is r...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
In 2026, memory-chip names Micron and Sandisk have surged past Nvidia, reshaping the AI stock landscape. This article...
Caterpillar stock is edging toward its 52-week high as orders surge and the Power & Energy arm expands. Yet investors...
Broadcom stock has many investors curious about its next move. This guide breaks down the buzz, the fundamentals, and...
SpaceX's much-anticipated IPO is expected to deliver a first-day surge that could surpass historic records. Valued ar...
The FDA recently approved fruit-flavored e-cigarettes, prompting scrutiny from health advocates and investors. A new ...
AST SpaceMobile targets a dramatic rise in value as it scales its satellite network and carrier partnerships, but pro...
The SEC has proposed scrapping Rule 611 and Rule 610(e), a step that could transform tokenized US stocks trading in D...